Discounted Cash Flow (DCF) Analysis Levered
Bruush Oral Care Inc. (BRSH)
$0.1635
-0.00 (-0.30%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 0.21 | 0.90 | 2.62 | 2.63 | 7.25 | 19.94 | 54.90 | 151.10 | 415.90 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | |||||||||
| Operating Cash Flow | -1.46 | -4.05 | -0.89 | -12.59 | -30.18 | -83.06 | -228.62 | -629.28 | -1,732.08 |
| Operating Cash Flow (%) | |||||||||
| Capital Expenditure | - | -0 | -0.01 | -0 | -0.02 | -0.05 | -0.14 | -0.38 | -1.04 |
| Capital Expenditure (%) | |||||||||
| Free Cash Flow | -1.46 | -4.06 | -0.90 | -12.59 | -30.19 | -83.11 | -228.76 | -629.65 | -1,733.12 |
Weighted Average Cost Of Capital
| Share price | $ 0.1,635 |
|---|---|
| Beta | 0.000 |
| Diluted Shares Outstanding | 7.34 |
| Cost of Debt | |
| Tax Rate | 63.74 |
| After-tax Cost of Debt | 1.81% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 4.110 |
| Total Debt | - |
| Total Equity | 1.20 |
| Total Capital | 1.20 |
| Debt Weighting | 0.00 |
| Equity Weighting | 100.00 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 0.21 | 0.90 | 2.62 | 2.63 | 7.25 | 19.94 | 54.90 | 151.10 | 415.90 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.46 | -4.05 | -0.89 | -12.59 | -30.18 | -83.06 | -228.62 | -629.28 | -1,732.08 |
| Capital Expenditure | - | -0 | -0.01 | -0 | -0.02 | -0.05 | -0.14 | -0.38 | -1.04 |
| Free Cash Flow | -1.46 | -4.06 | -0.90 | -12.59 | -30.19 | -83.11 | -228.76 | -629.65 | -1,733.12 |
| WACC | |||||||||
| PV LFCF | -30.19 | -79.83 | -211.05 | -557.99 | -1,475.23 | ||||
| SUM PV LFCF | -2,261.35 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 4.11 |
| Free cash flow (t + 1) | -1,767.78 |
| Terminal Value | -83,781.14 |
| Present Value of Terminal Value | -68,498.97 |
Intrinsic Value
| Enterprise Value | -70,760.32 |
|---|---|
| Net Debt | -0.07 |
| Equity Value | -70,760.24 |
| Shares Outstanding | 7.34 |
| Equity Value Per Share | -9,635.55 |